Evidence map›Paper›PMID 38153923›Full record

ArticleNeuro-oncology2024

Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities.

Martha Foltyn-Dumitru, Tobias Kessler, Felix Sahm, Wolfgang Wick, Sabine Heiland, Martin Bendszus, Philipp Vollmuth, Marianne Schell

Open access · greenAbstract read
In one paragraph

Article in Neuro-oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Martha Foltyn-DumitruDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Tobias KesslerDepartment of Neurology and Neurooncology Program, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
Felix SahmDepartment of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-5441-1962
Wolfgang WickDepartment of Neurology and Neurooncology Program, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-6171-634X
Sabine HeilandDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-9094-6769
Philipp VollmuthDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Marianne SchellDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-9754-1350
Heidelberg University · DEGerman Cancer Research Center · DE

Funding

Deutsche Forschungsgemeinschaft SFB 1389Else Kröner Fresenius Foundation 2022_EKCS.17Physician-Scientist Program of Heidelberg University
6 · The paper itself

Abstract

backgroundWhile the association between diffusion and perfusion magnetic resonance imaging (MRI) and survival in glioblastoma is established, prognostic models for patients are lacking. This study employed clustering of functional imaging to identify distinct functional phenotypes in untreated glioblastomas, assessing their prognostic significance for overall survival.

methodsA total of 289 patients with glioblastoma who underwent preoperative multimodal MR imaging were included. Mean values of apparent diffusion coefficient normalized relative cerebral blood volume and relative cerebral blood flow were calculated for different tumor compartments and the entire tumor. Distinct imaging patterns were identified using partition around medoids (PAM) clustering on the training dataset, and their ability to predict overall survival was assessed. Additionally, tree-based machine-learning models were trained to ascertain the significance of features pertaining to cluster membership.

resultsUsing the training dataset (231/289) we identified 2 stable imaging phenotypes through PAM clustering with significantly different overall survival (OS). Validation in an independent test set revealed a high-risk group with a median OS of 10.2 months and a low-risk group with a median OS of 26.6 months (P = 0.012). Patients in the low-risk cluster had high diffusion and low perfusion values throughout, while the high-risk cluster displayed the reverse pattern. Including cluster membership in all multivariate Cox regression analyses improved performance (P ≤ 0.004 each).

conclusionsOur research demonstrates that data-driven clustering can identify clinically relevant, distinct imaging phenotypes, highlighting the potential role of diffusion, and perfusion MRI in predicting survival rates of glioblastoma patients.

Indexed as

Brain NeoplasmsDiffusion Magnetic Resonance ImagingGlioblastomaAdultAgedCerebrovascular CirculationCluster AnalysisFemaleFollow-Up StudiesHumansMachine LearningMaleMiddle AgedPrognosisSurvival RateYoung Adultdiffusionglioblastomamachine learningperfusionprognostic biomarker

Identifiers

PMID38153923
PMCPMC11145444
OpenAlexW4390332116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.